603716 塞力医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-6.198-19.508-12.135-10.371-3.085
总资产报酬率 ROA (%)-2.232-6.780-4.344-3.726-1.207
投入资产回报率 ROIC (%)-3.044-9.860-6.032-4.957-1.554

边际利润分析
销售毛利率 (%)22.38718.32919.57519.86321.075
营业利润率 (%)-8.785-7.831-8.989-6.433-0.623
息税前利润/营业总收入 (%)-4.258-5.148-5.963-4.4772.019
净利润/营业总收入 (%)-8.835-10.680-7.815-8.241-1.476

收益指标分析
经营活动净收益/利润总额(%)93.23054.39633.2137.248-334.264
价值变动净收益/利润总额(%)-18.75143.9771.2353.104106.456
营业外收支净额/利润总额(%)1.2804.3856.32822.52832.797

偿债能力分析
流动比率 (X)1.7281.5221.7161.6071.867
速动比率 (X)1.4341.2841.4711.3781.600
资产负债率 (%)61.41666.00660.65962.18859.407
带息债务/全部投入资本 (%)48.10949.08944.91248.89250.254
股东权益/带息债务 (%)103.30198.970116.15997.70095.165
股东权益/负债合计 (%)64.91150.01559.73656.97161.242
利息保障倍数 (X)-0.918-1.693-1.641-1.1700.685

营运能力分析
应收账款周转天数 (天)336.350279.815295.469274.368226.183
存货周转天数 (天)114.87681.28085.05086.04375.943